L'Oréal strategically invests in Swiss biotech firm Timeline, aiming to pioneer the integration of longevity science into the beauty and wellness sectors. With a substantial Series D funding round and the promising 'Mitopure' molecule at its core, L'Oréal's venture into longevity underscores its commitment to fostering health and beauty synergies.